Company overview

PT Bio Farma Disingkat PT. Bio Farma (Persero)

Name

Entity type

PT (Limited Liability Company)

Location

Jawa Barat, Kota Bandung, Sukajadi, Pasteur

Address

Jalan Pasteur Nomor 28

Postal code

40161

Country

Indonesia

Court Cases (1)

13/Pdt.Sus-PHI/2020/PN Bdg

Primary goods traded

69.5% — 300220 (300220)
💉27.2% — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products (300241)
💉1.6% — Blood, human or animal, antisera, other blood fractions and immunological products (300212)
1.0% — Machinery, plant and laboratory equipment (841990)
0.8% — Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 (293499)

Accumulated tender value

Rp 3,000,840,074,249

Top Competitors

Most frequent co-bidders across 43 tenders

10 tenders

23%

PT Mangisi Makmur Sentosa

9 tenders

21%

7 tenders

16%

Loading chart...

Tender History

		Authority
3 November 2015	Pengadaan Vaksin Hepatitis B Bagi Satuan Muda Praja Ipdn Angkatan 26 Tahun Anggaran 2015	Kementerian Dalam Negeri	Rp 405,000,000
12 November 2025	Penyediaan Vaksin Dt Tambahan Tahun 2025	Kementerian Kesehatan	Rp 3,895,923,000
10 June 2016	Pengadaan Obat, Vaksin Dan Perbekalan Kesehatan (Penyediaan Vaksin Reguler) Human Papilloma Virus (Hpv)	Kementerian Kesehatan	Rp 1,200,612,789,000
22 November 2016	Vaksin Hepatitis B Bagi Nakes Berisiko	Kementerian Kesehatan	Rp 611,100,000
7 July 2017	Penyediaan Vaksin Reguler	Kementerian Kesehatan	Rp 16,500,000,000
18 July 2017	Penyediaan Reagen Campak, Ads Dan Bahan Laboratorium Eliminasi Campak/Difteri	Kementerian Kesehatan	Rp 1,928,407,200
15 September 2017	- Penyediaan Vaksin Reguler (Vaksin Je)	Kementerian Kesehatan	Rp 9,659,168,845
25 October 2017	- Anti Difteri Serum	Kementerian Kesehatan	Rp 1,602,000,000
15 December 2017	Anti Difteri Serum (Ads)	Kementerian Kesehatan	Rp 2,656,000,000
7 February 2018	- Penyediaan Reagen Campak, Ads Dan Bahan Laboratorium Eliminasi Campak/Difteri	Kementerian Kesehatan	Rp 3,176,448,000

0 of 43 row(s) selected.

Partner	Type	Total Value	Percentage
Sinovac Life Sciences Company Limited	seller	$1,794,331,519	50.33%
CV Bionest Asia	seller	$271,937,019	7.63%
Bharat Biotech International Limited	seller	$209,556,235	5.88%
Shenzhen Kangtai Biological Products Co., Ltd.	seller	$154,196,318	4.33%
Merck Sharp & Dohme Asia Pacific Services Pte Ltd	seller	$121,344,873	3.40%